IPARINTERPARFUMS INC
Health Care
Net Income (Loss) Attributable to Parent revised up 25.8% for FY 2021
This is the 2nd largest revision in IPAR's history.
Net Income (Loss) Attributable to Parent·FY 2021
Major restatement$110M▲ 25.8%
was$87.4M
Revised up. Any P/E built on the original was 20.5% too high.
Verify against SEC filingsShow
As reported$87.4M
Accepted 2022-03-010001753926-22-000273
Restated$110M
Accepted 2026-07-310001753926-26-001295
NetIncome · reported 4 times · point-in-time, survivorship-free. Every figure traces to its filing above.
Track this the moment it happens
Get a signal the next time IPAR — or any company on your watchlist — restates a number. Every signal lands with the diff and its source filing.